Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GlobalSurg-CovidSurg Week: Determining the Optimal Timing for Surgery Following SARS-CoV-2 Infection

NCT04509986 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT04509986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04509986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GlobalSurg-CovidSurg Week: Determining the Optimal Timing for Surgery Following SARS-CoV-2 Infection
Lead sponsor
University of Birmingham
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2020
Completion date
December 1, 2020
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, post-op complication, surgery